Aflac Inc (AFL) delivered better-than-expected financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) reached $2.49, significantly surpassing Wall Street's consensus estimate of $1.79 by $0.70. Revenue also impressed, totaling $4.7 billion, compared to the anticipated $4.4 billion.
This update provides insight into Aflac Inc's operational performance and financial health. With its principal business focusing on supplemental health and life insurance products, Aflac is a key player in the insurance industry. The company's segments include Aflac Japan, which is the leading insurer in Japan for cancer and medical policies, and Aflac U.S., which offers supplemental coverage that pays benefits regardless of other insurance.
Aflac will host its earnings conference call after market close to discuss these results and share additional commentary on business performance. Investors are encouraged to review the full earnings release and listen to management's insights for a complete understanding of the quarter's performance and future outlook.
As of November 7, 2025, Aflac boasts a market capitalization of $59.72 billion and a price-to-earnings ratio of 24.51. The company has a trailing twelve-month EPS of 4.42 and a remarkable dividend yield of 204.0%. Upcoming earnings are scheduled for August 2, 2026, with an EPS estimate of 1.8736 and revenue estimate of $4.4 billion.